Today: 22 May 2026
CoreWeave stock jumps 20% as CRWV heads into Feb. 26 earnings — what traders watch next
7 February 2026
2 mins read

CoreWeave stock jumps 20% as CRWV heads into Feb. 26 earnings — what traders watch next

New York, Feb 7, 2026, 05:52 (EST) — Markets aren’t open at this hour.

CoreWeave soared 20.5% on Friday, wrapping up the regular session at $89.95. The stock swung from a low of $77.10 to as high as $90.60 during the day. After hours, it inched up again, last trading at $90.20, a 0.3% lift.

Nvidia jumped 7.8% on Friday, snapping back after a turbulent stretch for AI stocks. Data-center spending talk sent fresh energy through the sector. Baird’s Ross Mayfield pointed to “real demand for AI products,” but said wild swings are still hitting the trade. Reuters

CoreWeave plans to post fourth-quarter and full-year 2025 results on Feb. 26, with a conference call set for 5 p.m. Eastern. CRWV shares have seen choppy action lately, and this report is shaping up as the next key catalyst.

CoreWeave on Thursday launched CoreWeave ARENA, a new lab aimed at letting customers push AI workloads to production scale before a full rollout. “CoreWeave is providing an element of understanding and cost-certainty that was missing from the AI race,” IDC research VP Dave McCarthy said. CoreWeave Investors

CoreWeave, a cloud infrastructure company, gives its clients access to GPUs and CPUs—the hardware behind training and running AI models, including generating results with inference. Its platform is built specifically for these heavy-duty applications.

On Friday, Chen Goldberg, who serves as senior vice president of engineering, sold 17,985 shares, a Form 4 filing shows. The average sale price landed at $79.6937. These were all disposed to satisfy taxes tied to restricted stock units, as is typical for equity awards. Prices in the transaction ranged from $79.29 up to $79.82, according to the same filing.

FMR LLC, in a separate filing, reported owning about 7.9 million CoreWeave shares—representing a 2.1% class stake—according to a Schedule 13G/A filed with the U.S. Securities and Exchange Commission on Feb. 5. That ownership snapshot is as of Dec. 31. Schedule 13G filings usually indicate a passive investment.

CoreWeave rolled out its new brand campaign on Friday, debuting “Ready for Anything, Ready for AI” during the Winter Olympics. The campaign features Chance the Rapper front and center. “’Ready for Anything, Ready for AI’ expresses our belief in what innovators need next,” said Chief Marketing Officer Jean English. CoreWeave

Complexity is on the rise. Large-scale capex projects just keep piling in, while investors are now splitting off as they make bets within the AI sector. As Saxo’s Charu Chanana put it, “investors are differentiating between who enables AI and who may be disrupted.” Reuters

Piling on, plaintiffs’ firm Kessler Topaz rolled out a securities class action against the company. Investors who bought shares between March 28 and Dec. 15, 2025, have until March 13 to seek lead-plaintiff status, per the firm. Their complaint points to issues with capacity and reliance on a third-party data-center supplier.

With markets shuttered until Monday, traders are watching Friday’s climb and paying close attention to the stock ahead of earnings. CoreWeave will report results on Feb. 26, with its earnings call scheduled for 5 p.m. Eastern.

Stock Market Today

  • NYSE's Martin Questions Nasdaq Rules Attracting SpaceX IPO
    May 22, 2026, 9:22 AM EDT. Lynn Martin, President of the New York Stock Exchange (NYSE), criticized some of the Nasdaq's listing rules used to attract SpaceX's public offering as "questionable." Speaking on Bloomberg Surveillance, Martin emphasized that market integrity should not be compromised for competitive gains between stock exchanges. She noted 2023 has been a strong year for initial public offerings (IPOs) across sectors and affirmed the NYSE's commitment to bringing more companies public. Martin's remarks highlight ongoing debates over regulatory standards and competitive practices in the IPO market.

Latest articles

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

22 May 2026
Akari Therapeutics shares more than doubled in premarket trading Friday after its lead cancer drug showed positive preclinical results in KRAS-mutated pancreatic cancer models and the company announced a $5.5 million private placement. The stock was quoted at $10.15, up from Thursday’s $5.14 close. Akari plans to start Phase 1 human trials of AKTX-101 by mid-2027. The company reported $2.8 million in cash at March 31.
BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

22 May 2026
Canaccord Genuity reaffirmed a Buy rating on Bank of Montreal ahead of its May 27 earnings report. BMO shares closed May 21 at C$220.06, near a 52-week high and up 23.5% year-to-date. The bank recently agreed to sell C$14.5 billion in loan and lease assets to Stonepeak, expecting a CET1 ratio boost but a C$900 million after-tax charge. Analyst consensus remains mixed, with most holding or selling.
Atmos Energy’s run in Texas faces new Wall Street target cut

Atmos Energy’s run in Texas faces new Wall Street target cut

22 May 2026
Morgan Stanley lowered its Atmos Energy price target to $183 from $195, maintaining an Equalweight rating. The move follows Atmos’ recent increase in its 2026 earnings outlook and annual dividend. Atmos shares closed at $177.46 on Thursday. Texas remains central to Atmos’ growth and regulatory strategy, with 65% of its rate base in the state.
Blockchain’s New Pitch: Tracking Supply-Chain Emissions for a Price
Previous Story

Blockchain’s New Pitch: Tracking Supply-Chain Emissions for a Price

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive
Next Story

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Go toTop